(Q40797394)

English

6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

0 references

0 references

0 references

0 references

0 references

Peter H. Kilmarx

14

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Zegabriel Tedla

object named as

Zegabriel Tedla

4

0 references

author name string

Taraz Samandari

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Tefera B Agizew

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Samba Nyirenda

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Thabisa Sibanda

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Nong Shang

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Barudi Mosimaneotsile

7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Oaitse I Motsamai

8

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Lorna Bozeman

9

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Margarett K Davis

10

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Elizabeth A Talbot

11

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Themba L Moeti

12

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Howard J Moffat

13

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Kenneth G Castro

15

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Charles D Wells

16

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

0 references

publication date

12 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

377

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

9777

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1588-1598

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of latent tuberculosis infection in HIV infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Scaling up ART treatment capacity: lessons learned from South Africa, Zimbabwe, and Botswana

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent transmission of tuberculosis in a cohort of HIV-1-infected female sex workers in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population-based prospective study of 301 pulmonary tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

High rates of clustering of strains causing tuberculosis in Harare, Zimbabwe: a molecular epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of recent infection with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in Northern Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of three regimens to prevent tuberculosis in HIV-infected patients with anergy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-10-producing T cells suppress immune responses in anergic tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Preventing latent tuberculosis among HIV-infected patients: efficacious and effective, yet inefficient?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American He

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960204-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(11)60204-3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40797394&oldid=1907611168"